Skip to main content

REVIEW article

Front. Chem.
Sec. Analytical Chemistry
Volume 13 - 2025 | doi: 10.3389/fchem.2025.1536222
This article is part of the Research Topic Recent Advances in Pharmaceutical Analysis: Applications and New Challenges for the Quality of Medicines View all 9 articles

Exploring Imaged Capillary Isoelectric Focusing Parameters for Enhanced Charge Variants Quality Control

Provisionally accepted
  • 1 Department of Pharmaceutical Sciences, University of Pavia, Pavia, Lombardy, Italy
  • 2 National Center for the Control and Evaluation of Medicine, National Institute of Health (ISS), Rome, Lazio, Italy

The final, formatted version of the article will be published soon.

    Biopharmaceuticals are increasingly utilised in the treatment of oncological, inflammatory, and autoimmune diseases, largely due to their exceptional specificity in targeting antigens. However, their structural complexity, heterogeneity, and sensitivity pose crucial challenges in their production, purification, and delivery. Charge heterogeneity analysis, a Critical Quality Attribute of these biomolecules used in their Quality Control, is often performed using separative analytical techniques such as imaged capillary Isoelectric Focusing (icIEF). Recognized as a gold standard by the industry, icIEF leverages a pH gradient to provide high-resolution profiling of charge variants in biotherapeutics. In this review, critical experimental parameters for icIEF method development in the context of biotherapeutic drug development and QC will be discussed. Key aspects, including sample preparation, capillary properties, carrier ampholytes, stabilizers, and detection are examined, and supported by recent literature. Advances in icIEF technology and its expanding applications underline its robustness, reproducibility, and compliance with regulatory standards, affirming its pivotal role in ensuring the identity and consistency of biological products.

    Keywords: icIEF, charge heterogeneities, Isoelectric Point, biotherapeutics development, QC

    Received: 28 Nov 2024; Accepted: 22 Jan 2025.

    Copyright: © 2025 Ghizzani, Ascione, Gonnella, Massolini and Luciani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Virginia Ghizzani, Department of Pharmaceutical Sciences, University of Pavia, Pavia, 27100, Lombardy, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.